Treating lung cancer in the NHS market
Improvements are needed in the present services and these improvements will cost more. Since the report from the Expert Advisory Group on Cancer was not accompanied by any promise of new or earmarked funding, the party line has been that improvements in cancer services should either be resource neut...
Gespeichert in:
Veröffentlicht in: | BMJ 1997-12, Vol.315 (7121), p.1548-1549 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Improvements are needed in the present services and these improvements will cost more. Since the report from the Expert Advisory Group on Cancer was not accompanied by any promise of new or earmarked funding, the party line has been that improvements in cancer services should either be resource neutral or withstand competition in a local priority setting process. [...]with the current market arrangements and in the short term the real decisions about allocating resources for lung cancer services are likely to take place in trusts. Because trusts have their own problems in undertaking redistribution of resources the responsibility for priority setting may well be pushed further down to clinical directorate level. |
---|---|
ISSN: | 0959-8138 1468-5833 1756-1833 |
DOI: | 10.1136/bmj.315.7121.1548a |